Published in Biom J on August 12, 2011
Letter to the editor. Biom J (2013) 1.08
Challenges in the clinical development of PI3K inhibitors. Ann N Y Acad Sci (2013) 0.91
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. J Biopharm Stat (2016) 0.80
Public Acceptability in the UK and USA of Nudging to Reduce Obesity: The Example of Reducing Sugar-Sweetened Beverages Consumption. PLoS One (2016) 0.79
Adaptive graph-based multiple testing procedures. Pharm Stat (2014) 0.77
Optimizing Trial Designs for Targeted Therapies. PLoS One (2016) 0.76
Seamless Phase IIa/IIb and enhanced dose-finding adaptive design. J Biopharm Stat (2015) 0.76
Author's reply: To PMID 21837623. Biom J (2013) 0.75
An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III Design. Front Public Health (2014) 0.75
Indian craniometric variability and affinities. Int J Evol Biol (2013) 0.75
A simple and flexible graphical approach for adaptive group-sequential clinical trials. J Biopharm Stat (2014) 0.75
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol (2017) 0.75
Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Stat Med (2003) 2.20
A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71
Multiple testing in clinical trials. Stat Med (1991) 1.55
Using prior information to allocate significance levels for multiple endpoints. Stat Med (1998) 1.31
General multistage gatekeeping procedures. Biom J (2008) 1.31
Some controversial multiple testing problems in regulatory applications. J Biopharm Stat (2009) 1.30
Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance. Control Clin Trials (1997) 1.19
A recycling framework for the construction of Bonferroni-based multiple tests. Stat Med (2009) 1.18
Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies. Stat Med (2007) 1.16
Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests. Stat Med (2008) 1.13
A flexible strategy for testing subgroups and overall population. Stat Med (2009) 1.11
Testing strategies in multi-dose experiments including active control. Stat Med (1998) 1.02
A consistency-adjusted alpha-adaptive strategy for sequential testing. Stat Med (2010) 1.00
Simultaneous confidence regions corresponding to Holm's step-down procedure and other closed-testing procedures. Biom J (2008) 0.96
Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures. Stat Med (2011) 0.95
The application of enhanced parallel gatekeeping strategies. Stat Med (2005) 0.92
Addressing multiplicity issues of a composite endpoint and its components in clinical trials. J Biopharm Stat (2011) 0.90
Challenges to multiple testing in clinical trials. Biom J (2010) 0.90
Testing non-inferiority and superiority for two endpoints for several treatments with a control. Pharm Stat (2010) 0.86
An efficient method for accommodating potentially underpowered primary endpoints. Stat Med (2008) 0.85
A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints. Pharm Stat (2009) 0.84
Alternative confidence regions for bonferroni-based closed-testing procedures that are not alpha-exhaustive. Biom J (2009) 0.84
Confidence regions for Bonferroni-based closed tests extended to more general closed tests. J Biopharm Stat (2011) 0.84
Gatekeeping procedures in dose-response clinical trials based on the Dunnett test. Pharm Stat (2006) 0.81
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biom J (2006) 2.61
Adaptive designs for confirmatory clinical trials. Stat Med (2009) 2.30
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biom J (2006) 2.16
Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med (2008) 1.97
Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood (2007) 1.78
A graphical approach to sequentially rejective multiple test procedures. Stat Med (2009) 1.71
Unbiased estimation of selected treatment means in two-stage trials. Biom J (2008) 1.29
Adaptive Dunnett tests for treatment selection. Stat Med (2008) 1.29
Selection and bias--two hostile brothers. Stat Med (2010) 1.24
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Stat Med (2009) 1.22
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union. Clin Cancer Res (2014) 1.17
Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies. Stat Med (2007) 1.16
Two-stage designs for experiments with a large number of hypotheses. Bioinformatics (2005) 1.13
Hierarchical testing of multiple endpoints in group-sequential trials. Stat Med (2010) 1.04
Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer (2003) 1.02
High-dimensional data analysis: selection of variables, data compression and graphics--application to gene expression. Biom J (2009) 1.02
Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis (2012) 0.98
The German version of the Oxford Shoulder Score--cross-cultural adaptation and validation. Arch Orthop Trauma Surg (2004) 0.97
Sharing clinical trial data on patient level: opportunities and challenges. Biom J (2014) 0.97
Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures. Stat Med (2011) 0.95
Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study. Gerontology (2003) 0.95
Impact of dental implant length on early failure rates: a meta-analysis of observational studies. J Clin Periodontol (2011) 0.93
Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials. Biom J (2013) 0.93
Diagnostic accuracy and reliability of muscle strength and endurance measurements in patients with chronic low back pain. J Rehabil Med (2009) 0.93
Implant survival in mandibles of irradiated oral cancer patients. Clin Oral Implants Res (2006) 0.92
Model-based dose finding under model uncertainty using general parametric models. Stat Med (2013) 0.91
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat (2007) 0.90
Early postpartum hysterectomy: incidence and risk factors. Acta Obstet Gynecol Scand (2010) 0.90
Optimized multi-stage designs controlling the false discovery or the family-wise error rate. Stat Med (2008) 0.90
Comparison of different methods of blood pressure measurements. Blood Press Monit (2007) 0.90
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine (2011) 0.90
Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma. Int Orthop (2010) 0.89
Adaptive designs for subpopulation analysis optimizing utility functions. Biom J (2014) 0.89
Rehabilitation of the severely atrophied maxilla by horseshoe Le Fort I osteotomy (HLFO). Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.89
Post hoc power estimation in large-scale multiple testing problems. Bioinformatics (2010) 0.88
Physiotherapy-based rehabilitation following disc herniation operation: results of a randomized clinical trial. Spine (Phila Pa 1976) (2007) 0.86
Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications. Biom J (2014) 0.86
Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study. Mov Disord (2009) 0.84
Reliability of EMG time-frequency measures of fatigue during repetitive lifting. Med Sci Sports Exerc (2002) 0.84
Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach. Stat Med (2013) 0.84
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim. Pharm Stat (2012) 0.83
Availability of mental health service providers and suicide rates in Austria: a nationwide study. Psychiatr Serv (2010) 0.82
Effects of N-acetylcysteine against systemic and renal hemodynamic effects of endotoxin in healthy humans. Crit Care Med (2007) 0.82
Effect of intensive care after cardiac arrest on patient outcome: a database analysis. Crit Care (2014) 0.80
Skateboarding injuries in Vienna: location, frequency, and severity. PM R (2010) 0.80
Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. Biom J (2009) 0.80
Cross-platform comparison of microarray data using order restricted inference. Bioinformatics (2011) 0.79
HSP-72 expression in pre-transplant donor kidney biopsies and post-transplant outcome. Transplantation (2004) 0.79
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion. J Biopharm Stat (2010) 0.79
Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples' by C. R. Mehta and S. J. Pocock. Stat Med (2012) 0.79
False discovery rate control in two-stage designs. BMC Bioinformatics (2012) 0.78
Connections between permutation and t-tests: relevance to adaptive methods. Stat Med (2014) 0.78
[Optimizing electrotherapy--a comparative study of 3 different currents]. Wien Klin Wochenschr (2002) 0.78
Long-term implant survival in the grafted maxilla: results of a 12-year retrospective study. Clin Oral Implants Res (2004) 0.78
Optimal choice of the number of treatments to be included in a clinical trial. Stat Med (2009) 0.77
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods. Stat Med (2012) 0.77
Multiple hypotheses testing based on ordered p values--a historical survey with applications to medical research. J Biopharm Stat (2011) 0.77
Adaptive graph-based multiple testing procedures. Pharm Stat (2014) 0.77
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug Administration. J Biopharm Stat (2010) 0.77
Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians. Biom J (2006) 0.77
Bridging the gap: a review of dose investigations in paediatric investigation plans. Br J Clin Pharmacol (2014) 0.77
An evaluation of methods for testing hypotheses relating to two endpoints in a single clinical trial. Pharm Stat (2012) 0.76
Author's reply: To PMID 21837623. Biom J (2013) 0.75
Letter to the editor "Comment on Qiu and Hwang (2007), Biometrics 63, 767-776". Biometrics (2009) 0.75
Sample size reassessment for a two-stage design controlling the false discovery rate. Stat Appl Genet Mol Biol (2015) 0.75
Effectiveness and tolerability of the herbal mixture Asparagus P on blood pressure in treatment-requiring antihypertensives. Phytomedicine (2006) 0.75
Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trial. Wien Klin Wochenschr (2008) 0.75
MCP2011--the 7th international conference on multiple comparison procedures. Biom J (2013) 0.75
Exact confidence bounds following adaptive group sequential tests. Biometrics (2009) 0.75
Special issue for dealing with multiplicity in drug development: current state and new directions--guest editors' note. J Biopharm Stat (2011) 0.75
Familywise error control in multi-armed response-adaptive two-stage designs. J Biopharm Stat (2011) 0.75
MCP2013 - 8th International Conference on Multiple Comparison Procedures. Biom J (2015) 0.75
Factors that influence the duration of splint wear in peripheral nerve lesions. Am J Phys Med Rehabil (2003) 0.75
The scientific work of Peter Bauer. Biom J (2007) 0.75
The contribution of Jürgen Läuter to multivariate statistics. Biom J (2005) 0.75
Simultaneous inference for several quantiles of a normal population with applications. Biom J (2012) 0.75
Repeated confidence intervals for adaptive group sequential trials. Stat Med (2007) 0.75
Detection of epistatic effects with logic regression and a classical linear regression model. Stat Appl Genet Mol Biol (2014) 0.75
MCP2009 - 6(th) International Conference on Multiple Comparison Procedures. Biom J (2010) 0.75